This announcement is a separate document:
傲农生物：中证鹏元关于关注福建傲农生物科技集团股份有限公司2022年半年度业绩预亏事项的公告
Aonong Biotech: China Securities Pengyuan's announcement on concerns about the pre-loss of the 2022 semi-annual performance of Fujian Aonong Biotechnology Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.